Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | NHERF1 | O14745 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28911954 | 0.94 | RXFP1 (0.43) | RXFP1MAPTKMT2AALDH1A1HPGD | |
| SCHEMBL13921790 | 0.88 | NPC1 (0.47) | RXFP1LMNAMAPK1RAB9ANPC1 | |
| SCHEMBL5201790 | 0.83 | RXFP1 (0.47) | RXFP1MAPTKMT2AALDH1A1HPGD | |
| SCHEMBL5205877 | 0.83 | RXFP1 (0.47) | RXFP1MAPTKMT2AALDH1A1HPGD | |
| SCHEMBL22208242 | 0.83 | MEN1 (0.47) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL22208244 | 0.83 | MEN1 (0.47) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL17348463 | 0.80 | CYP19A1 (0.46) | RXFP1MAPTKMT2AALDH1A1HPGD | |
| SCHEMBL4520536 | 0.80 | SMN1; SMN2 (0.50) | MAPTKMT2AALDH1A1HPGDLMNA | |
| SCHEMBL4520539 | 0.80 | SMN1; SMN2 (0.50) | MAPTKMT2AALDH1A1HPGDLMNA | |
| SCHEMBL14448784 | 0.77 | KMT2A (0.41) | RXFP1MAPTKMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | UDC IRELAND LIMITED (IE) | 2019-06-25 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| WO-2016046350-A1 | FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| EP-1874740-A1 | ELECTROLUMINESCENT DEVICE | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006114377-A1 | ELECTROLUMINESCENT DEVICE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | NR2E3, CRY1, ALDH1A2 | RXFP1 2147/4885MAPT 2708/4885KMT2A 1982/4885 |
| US-20090066231-A1 | Electroluminescent device | CD99, TEC, TYR | RXFP1 3924/4885MAPT 561/4885KMT2A 2657/4885 |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | NR2E3, CRY1, ALDH1A2 | RXFP1 2147/4885MAPT 2708/4885KMT2A 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.